Results

Total Results: over 10,000 records

Showing results for "diabetic".
Users also searched for: diabetes

81. When Taking an SGLT2 inhibitor, Remember To SSTOP (Stop SGLT2 Inhibitor Three days bef-O-re Procedures)! | PSNet
    psnet.ahrq.gov/web-mm/when-taking-sglt2-inhibitor-remember-sstop-stop-sglt2-inhibitor-three-days-bef-o-re
    February 01, 2023 - Euglycemic diabetic ketoacidosis (eDKA) was diagnosed, and he was transferred to the ICU for insulin … Euglycaemic diabetic ketoacidosis: does it exist?. … Euglycemic Diabetic Ketoacidosis. In: StatPearls . … Euglycemic diabetic ketoacidosis. … Prolonged ketosis in a patient with euglycemic diabetic ketoacidosis secondary to dapagliflozin.

82. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy Source: https:/ … Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy. … I see diabetic neuropathy patients and have practiced for 30+ years. … THIS IS NOT A VIABLE THERAPUTIC OPTION FOR USE DIABETIC NEUROPATHY. … Lidoderm is FDA approved for management of diabetic neuropathy.

83. Sb293
    meps.ahrq.gov/data_files/publications/st293/sb293.xml
    September 01, 2010 - The proportion of persons who used the three most commonly prescribed oral anti-diabetic medications … The average expenditures per user on prescribed anti-diabetic medications for 2006-2007 ($944) were nearly … The average out-of-pocket expenditure on anti-diabetic medications in 2006-2007 was $273 compared with …
    
    The mean expenditure per user for all types of prescribed anti-diabetic … medications, the top three classes of oral anti-diabetic medications and their combinations.

84. STATISTICAL BRIEF #293: Trends in the Pharmaceutical Treatment of Diabetes: A Comparison of Utilization and Expenditures, 1997 to 2007
    meps.ahrq.gov/data_files/publications/st293/draft/stat293.shtml
    September 01, 2010 - The proportion of persons who used the three most commonly prescribed oral anti-diabetic medications … The average expenditure per user on prescribed anti-diabetic medications for 2006-2007 ($944) were nearly … The average out-of-pocket expenditure on anti-diabetic medications in 2006-2007 was $273 compared with … Between 1997 and 2007, the total number of persons with diabetes who reported using oral anti-diabetic … medications, the top three classes of oral anti-diabetic medications and their combinations.

85. STATISTICAL BRIEF #293: Trends in the Pharmaceutical Treatment of Diabetes: A Comparison of Utilization and Expenditures, 1997 to 2007
    meps.ahrq.gov/data_files/publications/st293/stat293.shtml
    September 01, 2010 - The proportion of persons who used the three most commonly prescribed oral anti-diabetic medications … The average expenditure per user on prescribed anti-diabetic medications for 2006-2007 ($944) were nearly … The average out-of-pocket expenditure on anti-diabetic medications in 2006-2007 was $273 compared with … Between 1997 and 2007, the total number of persons with diabetes who reported using oral anti-diabetic … medications, the top three classes of oral anti-diabetic medications and their combinations.

86. Statistical Brief #293: Trends in the Pharmaceutical Treatment of Diabetes: A Comparison of Utilization and Expenditures, 1997 to 2007 (pdf file)
    meps.ahrq.gov/data_files/publications/st293/stat293.pdf
    September 01, 2010 - Between 1997 and 2007, the total number of persons with diabetes who reported using oral anti-diabetic … The proportion of persons with diabetes who used oral anti-diabetic medications increased from 59.9 … ● The average expenditure per user on prescribed anti- diabetic medications for 2006- 2007 ($944 … The average out- of-pocket expenditure on anti- diabetic medications in 2006- 2007 was $273 compared … medications, the top three classes of oral anti-diabetic medications and their combinations.

87. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - Efficacy and safety of lacosamide in painful diabetic neuropathy. … Duloxetine vs. placebo in patients with painful diabetic neuropathy. … Treatment of painful diabetic neuropathy with topical capsaicin. … Treatment of painful diabetic neuropathy with capsaicin 0.075%. … Mexiletine for treatment of chronic painful diabetic neuropathy.

88. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - Efficacy and safety of lacosamide in painful diabetic neuropathy. … Duloxetine vs. placebo in patients with painful diabetic neuropathy. … Treatment of painful diabetic neuropathy with topical capsaicin. … Treatment of painful diabetic neuropathy with capsaicin 0.075%. … Mexiletine for treatment of chronic painful diabetic neuropathy.

89. Data Points #3: Economic burden of diabetic foot ulcers and amputations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-foot-ulcer-amputation-economics/research
    March 08, 2011 - Data Points #3: Economic burden of diabetic foot ulcers and amputations Research Report March 8, 2011 … Overview Beneficiaries with a diabetic foot ulcer are seen by their outpatient health care provider … million, with another 57 million people estimated to have prediabetes.1 From 1980 to 2008, the number of diabetic … Many of these expenditures are likely related to comorbidities associated with diabetes like diabetic … Although much effort has been made to determine cost-effectiveness of the care of diabetic individuals

90. Exhibit 9. Top five minimal cut sets for the basic case | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/final-reports/stpra/stpraexh9.html
    April 01, 2018 - 142 (0.3) Staff not well-trained in infection control Event 450 (0.293) Obese, but not diabetic … to provide patient with instructions for weight reduction Event 450 (0.293) Obese, but not diabetic … 142 (0.3) Staff not well-trained in infection control Event 450 (0.293) Obese, but not diabetic … to provide patient with instructions for weight reduction Event 450 (0.293) Obese, but not diabetic … to provide patient with instructions for weight reduction Event 450 (0.293) Obese, but not diabetic

91. Data Points #3: Economic burden of diabetic foot ulcers and amputations | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/diabetes-foot-ulcer-amputation-economics/research
    March 08, 2011 - Home Evidence Reports Data Points #3: Economic burden of diabetic … Overview Beneficiaries with a diabetic foot ulcer are seen by their outpatient health care provider … Many of these expenditures are likely related to comorbidities associated with diabetes like diabetic … Although much effort has been made to determine cost-effectiveness of the care of diabetic individuals … Project Timeline Data Points #3: Economic burden of diabetic foot ulcers and amputations Mar 7,

92. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries … , 2006 to 2008 Diabetic Foot Ulcers Data Points #1 The prevalence of diabetes in the Medicare population … Levin and O’Neal’s The Diabetic Foot. 6th ed. St. Louis: Mosby; 2001. pp.13-32. 3. … The diabetic foot: grand overview, epidemiology, and pathogen- esis. … Diabetic Foot Ulcers.

93. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries … , 2006 to 2008 Diabetic Foot Ulcers Data Points #1 The prevalence of diabetes in the Medicare population … Levin and O’Neal’s The Diabetic Foot. 6th ed. St. Louis: Mosby; 2001. pp.13-32. 3. … The diabetic foot: grand overview, epidemiology, and pathogen- esis. … Diabetic Foot Ulcers.

94. Research Findings #30: Trends in the Pharmaceutical Treatment of Diabetes, 1997 to 2007 (pdf file)
    meps.ahrq.gov/data_files/publications/rf30/rf30.pdf
    September 15, 2010 - We also observe significant changes in patterns of use for anti-diabetic medications. … After adjusting for inflation, the average annual expenditures per user for anti-diabetic medications … Oral anti-diabetic medications generally work to reduce blood glucose concentration. … Non-insulin anti-diabetic injectables (exenatide) were first approved by the FDA in 2005. … medications, the top three classes of oral anti- diabetic medications and their combinations.

95. Logan A et al. 2007 "Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients." | Digital Healthcare Research
    digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/logan-et-al-2007-mobile
    January 01, 2007 - et al. 2007 "Mobile phone-based remote patient monitoring system for management of hypertension in diabetic … Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients … In Phase 2, 33 diabetic patients with uncontrolled ambulatory hypertension were enrolled in a 4-month … group) Study Participants Study participants for phase one included 24 hypertensive type 2 diabetic … For phase two, participants included 33 type 2 diabetic patients with uncontrolled ambulatory BP recruited

96. Module 7. Measuring and Benchmarking Clinical Performance | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/tools/pf-handbook/mod7.html
    March 01, 2022 - For this example, you might define the denominator as the number of diabetic patients who have had a … Or you might define the denominator more broadly from a population health perspective as any diabetic … For example, a monthly audit of performance on this metric might use diabetic patients receiving care … For example, when calculating the percentage of diabetic patients with low-density lipoprotein (LDL) … just the number of diabetic patients.

97. Comparative Effectiveness of Oral Hypoglycemics for Reducing Diabetic Nephropathy | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/diabetes-oral-medicines-nephropathy
    January 01, 2005 - Comparative Effectiveness of Oral Hypoglycemics for Reducing Diabetic Nephropathy Timeline … Research Report Comparative Effectiveness of Oral Hypoglycemics for Reducing Diabetic

98. Research Findings #30: Trends in the Pharmaceutical Treatment of Diabetes, 1997 to 2007
    meps.ahrq.gov/data_files/publications/rf30/rf30.shtml
    September 15, 2010 - We also observe significant changes in patterns of use for anti-diabetic medications. … From 1997 to 2007, the proportion of persons reporting treatment for diabetes who used oral anti-diabetic … After adjusting for inflation, the average annual expenditures per user for anti-diabetic medications … Oral anti-diabetic medications generally work to reduce blood glucose concentration. … Non-insulin anti-diabetic injectables (exenatide) were first approved by the FDA in 2005.

99. Data Points #3: Economic burden of diabetic foot ulcers and amputations | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/diabetes-foot-ulcer-amputation-economics
    March 08, 2011 - Data Points #3: Economic burden of diabetic foot ulcers and amputations Timeline March … March 08, 2011 Research Report Data Points #3: Economic burden of diabetic

100. Statistical Brief #34: The The Prevalence of Obesity and Other Chronic Health Conditions Among Diabetic Adults in the U.S. Community Population, 2001 (pdf file)
     meps.ahrq.gov/data_files/publications/st34/stat34.pdf
     January 01, 2001 - Statistical Brief #34: The The Prevalence of Obesity and Other Chronic Health Conditions Among Diabetic … 2001 Statistical Brief #34 The Prevalence of Obesity and Other Chronic Health Conditions among Diabetic … Percentage distribution of diabetic and nondiabetic adults in the U.S. community population, by BMI … Obese Source: Center for Financing, Access, and Cost Trends, AHRQ, Nondiabetic adult population Diabetic … Percentage of diabetic and nondiabetic adults in the U.S. community population with selected health